Skip to main content

Inotuzumab ozogamicin study reaches primary endpoint for ALL

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Inotuzumab ozogamicin study reaches primary endpoint for ALL

User login

Username

Password

Reset your password

Type	Lead	score